HSBC Holdings
NVCR icon

HSBC Holdings’s NovoCure NVCR Stock Holding History

HSBC Holdings’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$471K Sell
30,811
-879
-3% -$13.3K ﹤0.01% 2306
2026
Q1 		$342K Sell
31,690
-15,091
-32% -$188K ﹤0.01% 2403
2025
Q4 		$614K Sell
46,781
-8,254
-15% -$106K ﹤0.01% 2208
2025
Q3 		$697K Buy
55,035
+1,620
+3% +$21.6K ﹤0.01% 1949
2025
Q2 		$976K Buy
53,415
+41,059
+332% +$715K ﹤0.01% 1814
2025
Q1 		$219K Sell
12,356
-37,369
-75% -$849K ﹤0.01% 2576
2024
Q4 		$1.5M Sell
49,725
-9,069
-15% -$192K ﹤0.01% 1600
2024
Q3 		$910K Sell
58,794
-15,024
-20% -$272K ﹤0.01% 1741
2024
Q2 		$1.26M Sell
73,818
-75,530
-51% -$1.33M ﹤0.01% 1572
2024
Q1 		$2.33M Buy
149,348
+48,889
+49% +$719K ﹤0.01% 1402
2023
Q4 		$1.48M Buy
100,459
+64,244
+177% +$860K ﹤0.01% 1611
2023
Q3 		$592K Buy
36,215
+9,982
+38% +$288K ﹤0.01% 1925
2023
Q2 		$1.09M Sell
26,233
-302
-1% -$18.8K ﹤0.01% 1681
2023
Q1 		$1.6M Buy
26,535
+22,156
+506% +$1.77M ﹤0.01% 1599
2022
Q4 		$313K Sell
4,379
-14,013
-76% -$1.05M ﹤0.01% 2522
2022
Q3 		$1.43M Buy
18,392
+2,825
+18% +$220K ﹤0.01% 1679
2022
Q2 		$1.1M Buy
+15,567
New +$1.17M ﹤0.01% 1878
2021
Q3 		– Sell
-6,046
Closed -$1.34M – 3110
2021
Q2 		$1.34M Buy
6,046
+3,443
+132% +$670K ﹤0.01% 1623
2021
Q1 		$346K Sell
2,603
-1,160
-31% -$183K ﹤0.01% 2209
2020
Q4 		$651K Buy
3,763
+1,015
+37% +$139K ﹤0.01% 1996
2020
Q3 		$309K Buy
+2,748
New +$220K ﹤0.01% 2237
2019
Q3 		– Sell
-7,551
Closed -$477K – 3127
2019
Q2 		$477K Buy
7,551
+2,549
+51% +$129K ﹤0.01% 2088
2019
Q1 		$241K Buy
+5,002
New +$241K ﹤0.01% 2458

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

HSBC Holdings's NVCR Position: Q2 2026 in Review

HSBC Holdings reduced its NovoCure (NVCR) stake by 2.8% in Q2 2026, selling an estimated $13.3K and leaving 30,811 shares worth $471K. The position accounts for ﹤0.01% of the portfolio, ranked #2306.

HSBC Holdings first reported a position in NVCR in Q1 2019 and has held it in 23 quarters since. The position peaked at $2.33M in Q1 2024. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • HSBC Holdings held 30,811 shares of NovoCure worth $471K as of Q2 2026.
  • HSBC Holdings sold 879 NovoCure shares in Q2 2026, an estimated $13.3K.
  • NovoCure made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2306 holding.
  • HSBC Holdings first reported a position in NovoCure in Q1 2019 and has held it in 23 quarters since.
  • HSBC Holdings's NovoCure position peaked at $2.33M in Q1 2024.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.